Julie Fradette, PhD
Full Professor, Dpt of Surgery, Faculty of Medicine, Université Laval, Québec city, Canada
Researcher, Centre de recherche en organogénèse expérimentale de l’Université Laval / LOEX
Division of Regenerative Medicine, CHU de Québec Research Centre-Université Laval
"Engineering tissues using adipose-derived stem cells: from 3D models to in vivo wound repair"
Julie Fradette (PhD) is a Full Professor at Université Laval, department of Surgery, Faculty of Medicine. She is a researcher at the Centre LOEX de l’Université Laval, at the research center of the CHU de Québec-Université Laval since 2005. Her research activities focus on adipose-derived stem/stromal cells (ASCs) and their use in regenerative medicine. Her expertise encompasses tissue engineering of skin and various microvascularized connective tissues including human adipose and bone-like tissues. During her graduate studies, she studied skin epithelial stem cells for improvement of skin substitutes. Her postdoctoral training at the University of Pittsburgh established that ASCs and adipose tissue can be used for gene delivery using herpes-based viral vectors. Her research program is now focused on how human mesenchymal cell’s potential can be harnessed for tissue/organ reconstruction using cell-based, scaffold-free strategies. She is the director of the ThéCell network for cellular and tissular therapies for the province of Québec, Canada.
Abba C. Zubair, M.D., Ph.D.
Associate Professor, Transfusion Medicine and Cell Therapy
Abba C. Zubair, M.D., Ph.D., is a consultant in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Florida. Dr. Zubair is medical director of Transfusion Medicine and Stem Cell Therapy and serves as associate dean, Mayo Clinic School of Health Sciences in Florida. He joined the staff of Mayo Clinic in 2003 and holds the academic rank of associate professor of laboratory medicine and pathology, Mayo Clinic College of Medicine and Science.
Dr. Zubair earned his M.B.B.S. at Ahmadu Bello University in Zaria, Nigeria, and completed an internship at Murtala Mohammed General Hospital in Kano, Nigeria. He earned his Ph.D. at the University of Sheffield in England. He subsequently completed his postdoctoral fellowship at the University of Pennsylvania School of Medicine and his clinical residency in clinical pathology at the Hospital of University of Pennsylvania. He continued his training through a fellowship in transfusion medicine at the Joint Program in Transfusion Medicine at Brigham and Women Hospital and Children’s Hospital Boston. While pursuing his fellowship, he obtained a master’s degree in clinical trials and principles of drug development at Harvard University and Massachusetts Institute of Technology.
Dr. Zubair’s research focuses on the use of stem cells for regenerative medicine applications. His laboratory seeks to identify and characterize normal and cancer stem cells using immunophenotyping, molecular and cell culture techniques. Characterization of cancer stem cells will allow better insight into the mechanism of stem cell resistance to chemotherapy and might therefore lead to identification of new therapeutic targets, more effective anti-cancer therapies and chemoprevention. He recently received an award from NASA (Center for the Advancement of Science in Space) that will allow him to use the microgravity environment to grow stem cells that are of sufficient quality and quantity to use in the treatment of patients with stroke. He has given presentations on his research both nationally and internationally and has authored journal articles, abstracts and other written publications.
In addition to his research activities, Dr. Zubair is active in education, providing core didactic lectures for Mayo Clinic residents and fellows. He has also served as mentor and advisor to numerous research associates, residents and fellows. He holds full faculty privileges in Mayo Clinic Graduate School of Biomedical Sciences.
Dr. Zubair’s memberships with professional organizations include the International Society for Cellular Therapy (ISCT), American Association of Blood Banks, and American Society of Hematology.